期刊文献+

氨氯地平联合依那普利/叶酸片治疗H型高血压的临床分析 被引量:3

Clinical Analysis of Amlodipine Combined with Enalapril/Folic Acid Tablets for H-type Hypertension
下载PDF
导出
摘要 目的分析氨氯地平联合依那普利/叶酸片治疗H型高血压的临床疗效。方法选择2015年10月—2016年10月在我院门诊就诊的100例H型高血压患者,将其随机分为两组,对照组和观察组,每组50例。对照组给予硝苯地平缓释片联合依那普利/叶酸片治疗,观察组给予苯磺酸氨氯地平片联合依那普利/叶酸片进行治疗,对两组治疗效果进行比较。结果观察组舒张压为(77.4±3.6)mmHg,收缩压为(124.3±2.1)mmHg,Hcy为(9.7±3.9)μmol/L。治疗后,观察组与对照组血压、Hcy值对比,观察组均明显低于对照组,P<0.05。结论采用氨氯地平联合依那普利/叶酸片治疗H型高血压,疗效较好。 Objective To analyze the clinical efficacy of amlodipine combined with enalapril / folic acid tablets in the treatment of H-type hypertension. Methods 100 H-type hypertension patients admitted to our hospital from October 2015 to October 2016 were randomly divided into two groups: control group and observation group, with 25 cases in each group. Control group was given nifedipine sustained-release tablets combined with enalapril / folic acid tablets treatment, the observation group was given amlodipine besylate tablets combined with enalapril / folic acid tablets for treatment, the treatment effect of the two groups were compared. Results The diastolic pressure in the observation group was(77.4±3.6) mmHg, the systolic pressure was (124.3±2.1) mmHg, and Hcy was (9.7±3.9) μmol/L. After treatment, the blood pressure and Hcy value of the observation group were compared with the control group, and the observation group was signifcantly lower than the control group, P 〈 0.05. Conclusion The use of amlodipine combined with enalapril / folic acid tablets in the treatment of Hypertension, better curative effect, may be worth applying.
作者 葛长江 GE Changjiang(Department of Internal Medicine, Lianyungang Maternal and Child Health Care Hospital, Lianyungang Jiangsu 222069, Chin)
出处 《中国继续医学教育》 2017年第35期73-74,共2页 China Continuing Medical Education
关键词 氨氯地平 依那普利 叶酸片 H型高血压 amlodipine enalapril folic acid tablets H-type hypertension
  • 相关文献

参考文献7

二级参考文献55

  • 1Zhao D, Liu J, Wang W, et, al. Epidemiological transition of stroke in China: twenty - one - year observational study from the Sino - MONICA -Beijing Project[J]. Stroke, 2008,39(6) :1668 -1674.
  • 2Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta - analysis [J]. BMJ, 2002,325 (7374) :1202.
  • 3Wang X, Qin X, Demirtas H, et al. Efficacy of folic acid supplementation in stroke prevention: a meta - analysis [J]. Lancet, 2007, 369 (9576) :1876 -1882.
  • 4Rosa EM, Kramer C. Castrol association between coronary artery atherosclerosis and the intima - media thickness of the common carotid artery measured on ultrasonography [J]. Arq Bra Cardiol, 2003,80 ( 6) : 589 -592.
  • 5Haim M, Tanne D, Goldbourt U, et al. Serum homocysteine and long - term risk of myocardial infarction and sudden death in patients with coronaryheart disease [J]. Cardiology, 2007,107 (1) :52 - 56.
  • 6Biswas A, Ranjan R, Meena A, et, al. Homocystine levels, polymorphisms and the risk of ischemic stroke in young Asian Indians [J]. J Stroke Cerebrovasc Dis, 2009, 18 ( 20) : 103 - 11 o.
  • 7Tseng YL, Chang YY, Liu JS, et, al. Association of plasma homocysteine concentration with cerebral white matter hyperintensity on magnetic resonance in stroke patients [J]. J Neurol Sci, 2009,284 ( 112) : 36 - 39.
  • 8Zanchetti A. Bond MG. Hennig M. et al. European Lacidipine Study on Atherosclerosis investigators. Calcium antagonist lacidipine slows down progression of asympomatic carotid atheroselerosis. Principal results of the European lacidipine study on Atherosclerosis ( ELSA). a randomized doubleblind , long - term trial [J]. Circulation. 2002. 106 (19) :2422 -2427.
  • 9李建平,霍勇,刘平,秦献辉,关德明,葛均波,胡健,王燕妮,张馥敏,毛广运,徐希平.马来酸依那普利叶酸片降压、降同型半胱氨酸的疗效和安全性[J].北京大学学报(医学版),2007,39(6):614-618. 被引量:388
  • 10张红雨.马来酸依那普利叶酸片降压及降同型半胱氨酸的临床应用研究.桂林医学院,2012.

共引文献180

同被引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部